Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
NeuroDerm Ltd.
Age
18–55
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Outpatients.
Men and women 18-55 years of age.
Primary DSM-IV diagnosis of adult ADHD confirmed by senior physician
Capable and willing to provide informed consent
Able to adhere to the treatment schedule, and withdrawal of ongoing pharmacotherapy for the treatment of ADHD prior to the beginning of the study treatment and during the study drug treatment.
Subjects must be able to read, hear, write and speak the local language.
Subject has signed a written informed consent to participate in the study.
You may not be if
Unstable or significant medical disorder.
Current (within 12 months of baseline) primary or secondary depression.
History of substance abuse or dependence within the past 6 months
Any psychotic disorder (lifetime), including schizoaffective disorder, or major depression with psychotic features
Bipolar disorder
Eating disorder
Obsessive compulsive disorder
Post-traumatic stress disorder
Current generalized anxiety disorder
Presence of a personality disorder
Individuals with a significant other neurological disorder.
Use of any investigational drug within 4 weeks of the randomization visit
Known or suspected pregnancy
Women who are breast-feeding
Women of childbearing potential and not using a medically accepted form of contraception